Nature Biomedical Engineering

Nature Biomedical Engineering aspires to become the most prominent publishing venue in biomedical engineering by bringing together the most important advances in the discipline, enhancing their visibility by means of opinion and news articles, and providing overviews of the state of the art in each field through topic, disease or technology-focused review articles.

Engineered lipid nanoparticles for in vivo and durable editing of haematopoietic stem cells within humanized mice

---

XunZi, an AI biologist, reveals disease-modifying targets

---

EU’s fragmented early-stage medical device study requirements need reform

---

Rebalancing bone remodelling in osteoporosis

---

Sulfated polysaccharides target RANK Lys97 to inhibit osteoclast differentiation and reverse osteoporosis

---

European Union innovation needs regulatory science excellence centres

---

In vivo CRISPR base editing for treatment of Huntington’s disease

---

Sequencing-free spatial profiling of post-transcriptional regulation in fresh tissues using nanoneedle arrays

---